SARS-CoV-2 Total IgG Antibody Titer Assay Kit (Spike RBD)
1152.66 €
In Stock
quantity
product details
Catalog number: 544 - MBS8124208-96Tests
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 96Tests
RAS-A021
SARS-CoV-2 Spike RBD Titer Assay Kit
It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
982.45 €
RAS-T077
Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG1 Titer Serologic Assay Kit (Spike RBD)
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. Unprecedented vaccination campaigns have now begun with multiple candidates. To support these studies, ACRO has developed Anti-SARS-CoV-2 subtype antibody Serologic Assay kit including:IgG1, IgG2 IgG3, IgG4.
1074.92 €
RAS-T078
Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG3 Titer Serologic Assay Kit (Spike RBD)
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. Unprecedented vaccination campaigns have now begun with multiple candidates. To support these studies, ACRO has developed Anti-SARS-CoV-2 subtype antibody Serologic Assay kit including:IgG1, IgG2 IgG3, IgG4.
1074.92 €
RAS-T096
Anti-SARS-CoV-2 (Wild Type) Antibody IgA Titer Serologic Assay Kit (Spike RBD)
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.